Opinions
Jim Cramer - Mad Money
OncoCyte
OCX-Q
RISKY
Jul 12, 2021
he likes diagnostics and cancer treatments, so therefore likes this too. A spec buy.
$5.770
Stock price when the opinion was issued
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising